On August 13, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events" during a live webinar. The recorded webinar and presentation slides are available below.Webinar Faculty:
Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org.
Meeting: SITC Clinical Practice Guideline Webinar – Immune Checkpoint Inhibitor-related Adverse Events; Faculty: Paolo A. Ascierto, MD – Instituto Nazionale Tumori IRCCS, Fondazione 'G. Pascale'; Julie R. Brahmer, MD, MSc – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Marc S. Ernstoff, MD – National Institutes of Health; Gregory A. Masters, MD, FACP, FASCO – Helen F. Graham Cancer Center; Igor Puzanov, MD, MSCI, FACP – Roswell Park Comprehensive Cancer Center; Date: August 13, 202101:02:18
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com